Epista Life Science
Epista Life Science is an IT services and consultancy firm assisting Life Science companies worldwide
- The investment thesis is anchored in continued organic growth coupled with further internationalization via M&A.
- Organic growth is to be driven by targeted value propositions towards all types of life science customers ranging from mature pharma companies to biotech start-ups.
- M&A will be deployed to accelerate further international growth and a consolidation of similar niche focused IT services firms dedicated to the life science industry
Main Transformation Initiatives
- Further develop the organization for international growth
- Develop current service offerings
- Complement organic growth by pursuing strategic acquisitions
FSN Ownership 64%
Sales 2022 EUR 18m
CEO Klavs Esbjerg
Chairperson Per Kogut
Pointperson Nicholas Hjorth